Published Date: 14 Apr 2026
Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.
Read Full News1.
Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.
2.
Can Alternating Venetoclax Regimens Improve AML Outcomes?
3.
Cancer detection recovered following pandemic disruptions
4.
COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment
5.
Research identifies nearly 200 potential breast carcinogens in food packaging materials
1.
A Clinical Review of Novel Therapeutics for Rare Cancers in the Genomics Era
2.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
3.
Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells
4.
From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine
5.
Uncovering the Causes of Thrombocytosis: A Journey to Improved Health
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Chemotherapy: What to Expect
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation